| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 21 |
| NetGPI | no | yes: 0, no: 21 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0005737 | cytoplasm | 2 | 3 |
| GO:0031974 | membrane-enclosed lumen | 2 | 2 |
| GO:0031981 | nuclear lumen | 5 | 2 |
| GO:0032838 | plasma membrane bounded cell projection cytoplasm | 4 | 2 |
| GO:0043233 | organelle lumen | 3 | 2 |
| GO:0070013 | intracellular organelle lumen | 4 | 2 |
| GO:0097014 | ciliary plasm | 5 | 2 |
| GO:0099568 | cytoplasmic region | 3 | 2 |
| GO:0110165 | cellular anatomical entity | 1 | 3 |
Related structures:
AlphaFold database: Q4QG61
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0003824 | catalytic activity | 1 | 22 |
| GO:0016740 | transferase activity | 2 | 22 |
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_C14_Caspase3-7 | 256 | 260 | PF00656 | 0.429 |
| CLV_C14_Caspase3-7 | 53 | 57 | PF00656 | 0.259 |
| CLV_NRD_NRD_1 | 22 | 24 | PF00675 | 0.457 |
| CLV_NRD_NRD_1 | 262 | 264 | PF00675 | 0.529 |
| CLV_NRD_NRD_1 | 6 | 8 | PF00675 | 0.527 |
| CLV_PCSK_KEX2_1 | 22 | 24 | PF00082 | 0.455 |
| CLV_PCSK_KEX2_1 | 262 | 264 | PF00082 | 0.529 |
| CLV_PCSK_KEX2_1 | 35 | 37 | PF00082 | 0.458 |
| CLV_PCSK_KEX2_1 | 6 | 8 | PF00082 | 0.527 |
| CLV_PCSK_PC1ET2_1 | 35 | 37 | PF00082 | 0.513 |
| CLV_PCSK_SKI1_1 | 179 | 183 | PF00082 | 0.361 |
| CLV_PCSK_SKI1_1 | 41 | 45 | PF00082 | 0.499 |
| DEG_MDM2_SWIB_1 | 135 | 142 | PF02201 | 0.399 |
| DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.583 |
| DOC_CKS1_1 | 248 | 253 | PF01111 | 0.440 |
| DOC_CYCLIN_RxL_1 | 187 | 198 | PF00134 | 0.377 |
| DOC_MAPK_gen_1 | 41 | 49 | PF00069 | 0.266 |
| DOC_MAPK_MEF2A_6 | 193 | 201 | PF00069 | 0.361 |
| DOC_MAPK_MEF2A_6 | 41 | 49 | PF00069 | 0.265 |
| DOC_PP2B_LxvP_1 | 197 | 200 | PF13499 | 0.362 |
| DOC_PP4_FxxP_1 | 42 | 45 | PF00568 | 0.294 |
| DOC_WW_Pin1_4 | 247 | 252 | PF00397 | 0.700 |
| LIG_BRCT_BRCA1_1 | 131 | 135 | PF00533 | 0.375 |
| LIG_CtBP_PxDLS_1 | 89 | 94 | PF00389 | 0.265 |
| LIG_FHA_1 | 180 | 186 | PF00498 | 0.349 |
| LIG_FHA_1 | 200 | 206 | PF00498 | 0.375 |
| LIG_FHA_1 | 242 | 248 | PF00498 | 0.652 |
| LIG_FHA_2 | 248 | 254 | PF00498 | 0.611 |
| LIG_LIR_Gen_1 | 25 | 34 | PF02991 | 0.314 |
| LIG_LIR_Nem_3 | 145 | 149 | PF02991 | 0.368 |
| LIG_LIR_Nem_3 | 25 | 30 | PF02991 | 0.324 |
| LIG_LIR_Nem_3 | 73 | 79 | PF02991 | 0.269 |
| LIG_Pex14_1 | 8 | 12 | PF04695 | 0.496 |
| LIG_Pex14_2 | 127 | 131 | PF04695 | 0.237 |
| LIG_Pex14_2 | 135 | 139 | PF04695 | 0.360 |
| LIG_RPA_C_Plants | 104 | 115 | PF08784 | 0.237 |
| LIG_SH2_CRK | 79 | 83 | PF00017 | 0.360 |
| LIG_SH2_STAT3 | 230 | 233 | PF00017 | 0.346 |
| LIG_SH2_STAT5 | 16 | 19 | PF00017 | 0.246 |
| LIG_SH2_STAT5 | 166 | 169 | PF00017 | 0.518 |
| LIG_SH2_STAT5 | 184 | 187 | PF00017 | 0.308 |
| LIG_SH2_STAT5 | 223 | 226 | PF00017 | 0.372 |
| LIG_SH2_STAT5 | 230 | 233 | PF00017 | 0.354 |
| LIG_SH3_3 | 228 | 234 | PF00018 | 0.346 |
| LIG_WRC_WIRS_1 | 240 | 245 | PF05994 | 0.541 |
| MOD_CK1_1 | 242 | 248 | PF00069 | 0.513 |
| MOD_GlcNHglycan | 158 | 161 | PF01048 | 0.520 |
| MOD_GlcNHglycan | 189 | 192 | PF01048 | 0.378 |
| MOD_GlcNHglycan | 52 | 55 | PF01048 | 0.470 |
| MOD_GSK3_1 | 195 | 202 | PF00069 | 0.353 |
| MOD_GSK3_1 | 204 | 211 | PF00069 | 0.327 |
| MOD_GSK3_1 | 249 | 256 | PF00069 | 0.494 |
| MOD_NEK2_1 | 156 | 161 | PF00069 | 0.492 |
| MOD_NEK2_1 | 195 | 200 | PF00069 | 0.419 |
| MOD_NEK2_1 | 90 | 95 | PF00069 | 0.342 |
| MOD_NEK2_2 | 270 | 275 | PF00069 | 0.577 |
| MOD_PKA_2 | 137 | 143 | PF00069 | 0.482 |
| MOD_PKA_2 | 50 | 56 | PF00069 | 0.249 |
| MOD_Plk_1 | 179 | 185 | PF00069 | 0.354 |
| MOD_Plk_1 | 195 | 201 | PF00069 | 0.369 |
| MOD_Plk_1 | 47 | 53 | PF00069 | 0.360 |
| MOD_Plk_2-3 | 253 | 259 | PF00069 | 0.613 |
| MOD_Plk_4 | 232 | 238 | PF00069 | 0.410 |
| MOD_ProDKin_1 | 247 | 253 | PF00069 | 0.709 |
| MOD_SUMO_rev_2 | 221 | 229 | PF00179 | 0.404 |
| TRG_ER_diArg_1 | 22 | 24 | PF00400 | 0.256 |
| TRG_ER_diArg_1 | 262 | 265 | PF00400 | 0.535 |
| TRG_ER_diArg_1 | 36 | 39 | PF00400 | 0.256 |
| TRG_ER_diArg_1 | 6 | 8 | PF00400 | 0.556 |
| TRG_NLS_Bipartite_1 | 22 | 39 | PF00514 | 0.332 |
| TRG_Pf-PMV_PEXEL_1 | 262 | 266 | PF00026 | 0.531 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N0P896 | Leptomonas seymouri | 79% | 100% |
| A0A0N1PCD6 | Leptomonas seymouri | 33% | 95% |
| A0A0S4IK22 | Bodo saltans | 63% | 98% |
| A0A1X0NN04 | Trypanosomatidae | 67% | 100% |
| A0A1X0P3F1 | Trypanosomatidae | 39% | 80% |
| A0A3Q8I9N9 | Leishmania donovani | 96% | 100% |
| A0A3R7K9Z6 | Trypanosoma rangeli | 36% | 91% |
| A0A3R7MES7 | Trypanosoma rangeli | 71% | 100% |
| A0A3S7XB94 | Leishmania donovani | 32% | 96% |
| A4H781 | Leishmania braziliensis | 91% | 100% |
| A4HPL2 | Leishmania braziliensis | 32% | 96% |
| A4HVM1 | Leishmania infantum | 96% | 100% |
| A4ID52 | Leishmania infantum | 32% | 96% |
| D0A6N3 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 68% | 77% |
| D0A8K2 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 38% | 90% |
| E9APB7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 95% | 100% |
| E9ATC4 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 32% | 96% |
| Q4Q173 | Leishmania major | 32% | 100% |
| V5BK55 | Trypanosoma cruzi | 70% | 100% |
| V5BS52 | Trypanosoma cruzi | 33% | 91% |